Non-interventional Study of Lenalidomide / Dexamethasone as First Line Therapy in Patients With Multiple Myeloma
NCT02537808
·
clinicaltrials.gov ↗
COMPLETED
Status
172
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Sponsor
iOMEDICO AG